Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Marinos C. Dalakas MD, FAAN Advisory Board

Argye Elizabeth Hillis MD, MA Associate Editor

See All Experts

story of the week

Published in Neurology

Journal Scan / Research · November 23, 2023

Epilepsy With Generalized Tonic–Clonic Seizures Alone: Electroclinical Features and Prognostic Patterns

Epilepsia

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Shampa Ghosh PhD

Jitendra Sinha PhD

Epilepsia

Epilepsy with generalized tonic-clonic seizures alone: Electroclinical features and prognostic patterns

Epilepsia 2023 Oct 23;[EPub Ahead of Print], E Cerulli Irelli, J Gesche, S Schlabitz, F Fortunato, C Catania, A Morano, A Labate, BJ Vorderwülbecke, A Gambardella, B Baykan, M Holtkamp, C Di Bonaventura, CP Beier

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Epilepsy With Generalized Tonic–Clonic Seizures Alone: Electroclinical Features and Prognostic Patterns

Additional Info

Epilepsy with generalized tonic-clonic seizures alone: Electroclinical features and prognostic patterns

Further Reading

Association of Health and Lifestyle Factors With Dementia Risk in Former Professional Soccer Players

Association of the Cervical Canal Area With Disability and Progression in People With MS

Directional Subthalamic Deep Brain Stimulation Better Improves Gait and Balance Disorders in Patients With Parkinson's Disease

Induction Cyclophosphamide With Maintenance Immunosuppression for High-Risk Myasthenia Gravis

Non-Invasive Continuous Oral Delivery of Solid Levodopa–Carbidopa for the Management of Parkinson's Disease

Low-Frequency Deep Brain Stimulation During Non-REM Sleep Modifies Memory Retention in Patients With Parkinson's Disease

Toward Personalized Dosing of B-Cell–Depleting Therapy

Safety and Efficacy of Intravenous Recombinant Human Prourokinase for Acute Ischaemic Stroke Within 4.5 Hours After Stroke Onset

Hypogammaglobulinemia and Severe Infections in Patients With MS on Anti-CD20 Agents

Risk of Hypertension in Patients With MS Treated With Teriflunomide vs Dimethyl Fumarate

Addition of Cilostazol to Antiplatelet Therapy for In-Stent Restenosis After Carotid Artery Stenting

Recently Updated